A groundbreaking study emerging from The Jackson Laboratory (JAX) suggests that routine eye examinations could soon enable physicians to detect the early vascular signs of Alzheimer’s disease and related dementias long before cognitive symptoms manifest. The research centers on the retina, whose intricate network of blood vessels mirrors changes occurring within the brain, thus providing a non-invasive window into neurodegenerative processes.
In recently published findings in the journal Alzheimer’s & Dementia, scientists investigated the impact of the MTHFR^677C>T genetic mutation—a variant present in up to 40% of the population—on retinal vasculature in a mouse model. This mutation has been widely associated with an increased risk of Alzheimer’s disease, and the study’s detailed vascular analysis revealed profound abnormalities in the retinal blood vessels of affected mice. These included twisting, narrowing, swelling, and a reduction in branching of retinal arteries beginning as early as six months of age, indicative of cerebrovascular dysfunction paralleling changes detected in the brain.
The retina’s fundamental role as an extension of the central nervous system means that the cells and microvasculature within this tissue share remarkable similarities with those in the brain. This biological continuity underlies the hypothesis that retinal blood vessel anomalies can serve as precursors to cerebral vascular pathologies implicated in dementia. The accessibility of the retina—viewable non-invasively via the pupil—positions it as a vital biomarker for early diagnosis, well before symptomatic cognitive decline.
Neuroscientist Alaina Reagan, who led this research at JAX alongside professor Gareth Howell, emphasizes the translational potential of their findings. Reagan explains that distorted and irregular vascular morphologies in the retina could reflect systemic hypertension and compromised blood flow, which are known risk factors for neurodegeneration. The murine retinal vessel abnormalities observed parallel vascular features noted in human dementia cases, signaling that retinal imaging could become a critical screening tool in clinical practice.
Specific structural abnormalities identified include “waviness” or looping of vessels, arterial constriction, and diminished vessel density—all of which compromise optimal nutrient and oxygen delivery to neural tissues. These pathological signatures highlight a vascular component to neurodegenerative disease etiology, a facet that is increasingly recognized as central to the development and progression of Alzheimer’s.
Further corroborating this vascular link, previous studies by the same group demonstrated analogous vascular reductions and blood flow impairments in the cortex of MTHFR^677C>T mutant mice. Such cerebrovascular insufficiencies are subtle yet significant contributors to neuronal dysfunction and cognitive decline, reinforcing the importance of vascular health monitoring as part of dementia risk assessment.
At a molecular level, the research also uncovered disrupted protein expression patterns governing cellular energy metabolism, proteostasis, and vascular structural integrity within both the brain and retinal tissues of mutated mice. These perturbations sketched a complex interplay of mechanisms leading to vascular inefficiency and neurodegenerative vulnerability, underscoring the multifactorial nature of Alzheimer’s disease pathogenesis.
Notably, the study reveals sex-specific differences, with female mice exhibiting more severe vascular impairments as they aged, including marked reductions in vessel density and branching by 12 months. This mirrors epidemiological data showing higher prevalence and severity of dementia in women, suggesting that the interplay of genetic, vascular, and sex-related factors could inform personalized approaches to screening and intervention.
The research team is now collaborating with clinical partners at Northern Light Acadia Hospital in Bangor, Maine, to translate these murine findings to human populations. Their goal is to verify whether retinal vascular changes observed in MTHFR^677C>T carriers are detectable with current ophthalmologic imaging technologies and whether these changes can reliably forecast dementia risk in patients.
This translational step aims to integrate retinal vascular assessment into standard vision examinations, especially for individuals over 50 who routinely seek eye care. Since vision impairment is common in this demographic, leveraging ophthalmic screenings to identify vascular biomarkers could provide a pivotal opportunity for early diagnostic intervention, potentially extending the window for therapeutic strategies before irreversible brain damage occurs.
Overall, this study offers compelling evidence that the retina is not merely a passive extension of the brain but an active biomarker reflecting systemic and neural health. By illuminating the vascular underpinnings of Alzheimer’s risk through a genetically relevant mouse model, the research paves the way for innovative, accessible methods to identify and perhaps mitigate dementia long before clinical symptoms surface.
As our understanding of the vascular contributions to neurodegeneration advances, the prospect of routine eye exams serving as early detectors of Alzheimer’s disease becomes increasingly tangible. Such non-invasive, cost-effective diagnostic tools promise to revolutionize preventive neurology and offer hope in tackling one of the most challenging public health issues of our time.
Subject of Research: Animals
Article Title: Retinal vascular dysfunction in the Mthfr677C>T mouse model of cerebrovascular disease
News Publication Date: 31-Jul-2025
Web References:
- Study in Alzheimer’s & Dementia
- Previous related work at The Jackson Laboratory
- 2022 Study on brain vascular changes
References:
Reagan, A., MacLean, M., Cossette, T.L., & Howell, G.R. (2025). Retinal vascular dysfunction in the Mthfr677C>T mouse model of cerebrovascular disease. Alzheimer’s & Dementia. DOI: 10.1002/alz.70501
Image Credits: The Jackson Laboratory
Keywords: Alzheimer disease, Dementia, Cognitive disorders, Psychiatric disorders, Psychiatry
